<DOC>
	<DOCNO>NCT01702012</DOCNO>
	<brief_summary>A 12 month multi-center randomization control study . Participants randomize either lifestyle education program meal replacement regimen Almased , initial examination eligibility criterion . Primary outcome-HbA1c</brief_summary>
	<brief_title>Almased Multi-Center Diabetes Intervention Trial</brief_title>
	<detailed_description>Age 21 + Male/Female gender Type 2 Diabetes Non-insulin dependent BMI 25-40 kg/m HbA1c 7.5-10 %</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>• Gender : Men woman eligible Type 2 diabetes mellitus : Diabetes mellitus determine medical record , current treatment , verification personal health care provider , test result meeting 2010 American Diabetes Association criterion fast glucose ≥126 mg/dl , symptom hyperglycemia casual plasma glucose &gt; 200 mg/dl twohour plasma glucose ≥200 mg/dl 75 gram oral glucose load . Individuals clinical history strongly suggestive type 1 diabetes exclude . Individuals take oral hypoglycemic medication diet exercise eligible . Subjects take insulin eligible entry study . Body mass index : Overweight obese individual , body mass index 25 40 kg/m2 , eligible . Weight loss recommend overweight diabetic participant one cardiovascular risk factor . Age : Individuals older 21 year eligible . Ethnicity : All ethnic group eligible study . Blood pressure : AMDIT enroll individual whose blood pressure least moderate control . For safety purpose , moderate control define study systolic value 160 mm/Hg diastolic value 100 mm/Hg . Individuals whose blood pressure exceed level screen advise seek treatment may reevaluate follow initiation antihypertensive treatment . Glycemic control : AMDIT enroll individual whose HbA1c 7.5 10 % . Individuals whose HbA1c exceed level may require urgent care tell seek treatment may also reevaluate inclusion . Lipid control : Individuals fast triglyceride concentration le 500 mg/dl eligible . Willingness participate : Participants must willing randomize either Almased Lifestyle Intervention follow protocol assign . Individuals must willing modify diet activity assign Lifestyle Intervention . • Unable unwilling give inform consent communicate local study staff ; Psychotic disorder bipolar disorder , hospitalization depression past six month ; Selfreport alcohol substance abuse within past twelve month , current consumption 14 alcoholic drink per week , and/or current acute treatment rehabilitation program problem ; Plans relocate area serve AMDIT travel plan permit full participation study ; Known allergy soy dairy ; Current use medication weight loss ; Selfreported inability walk two block ; History bariatric surgery , small bowel resection , extensive bowel resection ; Chronic treatment systemic corticosteroid weight gain associated steroid may interfere intervention goal ; Candidates definite plan move area within study period ; Candidates dietary practice , behavior , attitude would substantially limit adherence intervention ; Currently pregnant nursing ; Cancer require treatment past five year , except nonmelanoma skin cancer cancer clearly cured opinion investigator carry excellent prognosis ( e.g . Stage 1 cervical cancer ) ; HIV positive ( selfreport ) , due effect weight body composition HIV medication use treat HIV ; Active tuberculosis ( selfreport ) ; Cardiovascular cardiopulmonary disease include heart attack procedure within past three month ; participation cardiac rehabilitation program within last three month ; stroke history/treatment transient ischemic attack past three month ; document history pulmonary embolus past six month ; unstable angina pectoris angina pectoris rest ; know history cardiac arrest ; know history complex ventricular arrhythmia rest exercise ; know history uncontrolled atrial fibrillation ( heart rate 100 beat per minute ) ; know history NYHA Class III IV congestive heart failure ; know history acute myocarditis , pericarditis hypertrophic myocardiopathy ; know history clinically significant aortic stenosis ; know history leave bundle branch block cardiac pacemaker unless evaluated cardiologist ; cardiac defibrillator ; heart transplant ; know history aortic aneurysm least 7 cm diameter aortic aneurysm repair ; Renal disease : urine dipstick protein 4+ ( equivalent approximately &gt; 1 g/day ) , serum creatinine exceed 1.4 mg/dl ( woman ) 1.5 mg/dl ( men ) , currently receive dialysis ; Known history chronic obstructive pulmonary disease would limit ability follow protocol ; Selfreported chronic hepatitis B C cirrhosis ; Inflammatory bowel disease require treatment past year ; Known history Cushing 's syndrome ( clinic diagnosis selfreport ) ; Known history Acromegaly ( clinical diagnosis selfreport ) ; Amputation low limb result nontraumatic cause ; Any major organ transplant ( include cornea hair transplant ) ; Conditions specifically mention may serve criterion exclusion discretion clinical site .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Diabetes-Obesity</keyword>
</DOC>